Investing Profile

Isaac Manke

InvestorVC
Partner at Acorn Bioventures
Photo of Isaac Manke, Partner at Acorn Bioventures

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Deutsche Bank Network
282 CONNECTIONS
AllianceBernstein Network
16 CONNECTIONS
cb
$100K - $5.0M
$1.5M
7
CompanyStageDateRound SizeTotal Raised
OnKure Therapeutics
Post Ipo EquityOct 2024$65M
Series CMay 2023$54M
Series BMar 2021$57M
$180M
Q32 Bio
Post Ipo EquityMar 2024$42M
Series BOct 2020$60M
$200M
Co-investors: Diyong Xu (OrbiMed), David Grayzel (Atlas Venture)
ONK Therapeutics
Series AJan 2022$22M
$22M
True North Therapeutics
Series CDec 2015$40M
$40M
Board Member True North TherapeuticsPresent
Board Member Message PharmaceuticalsPresent
Board Member Addex TherapeuticsPresent
Board Member ReViralPresent
Board Member Star TherapeuticsPresent
Board Member Chardan Healthcare Acquisition 2 CorpPresent
Board Member ONK TherapeuticsPresent
Board Member Q32 Bio Inc.Present
Board Member OnKure TherapeuticsPresent
Senior Analyst Health AdvancesPresent
Associate Analyst - Biotechnology Equity Research Deutsche BankPresent
Biotechnology Research Associate AllianceBernsteinPresent
General Partner New Leaf Venture PartnersPresent
Partner Acorn BioventuresPresent
Sign in with Google →
Sign in with Google →